NASDAQ | ETF
The investment seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the NASDAQ Biotechnology Index®.
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund&!39;s investment objective.
The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical.
The fund is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 8.15% |
GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 7.42% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 7.22% |
BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 6.13% |
ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 5.68% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.14% |
ALXN | Alexion Pharmaceuticals Inc | Healthcare | Biotechnology | 3.02% |
SGEN | Seagen Inc | Healthcare | Biotechnology | 2.25% |
INCY | Incyte Corporation | Healthcare | Biotechnology | 2.09% |
BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.91% |
ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 1.60% |
MYL | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.35% |
SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 1.29% |
NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.16% |
SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 1.15% |
NVCR | Novocure Ltd | Healthcare | Medical Devices | 1.11% |
JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 1.03% |
IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.02% |
TECH | Bio-Techne Corp | Healthcare | Biotechnology | 1.01% |
GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 0.96% |